Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Istituto De Angeli is a prominent pharmaceutical contract development and manufacturing organization (CDMO) located in Reggello, Italy. Founded in 1898, the company has a long-standing reputation for excellence in pharmaceutical production and was formerly a key manufacturing site for Boehringer Ingelheim. In 2009, it was acquired by the Fareva Group, one of the world’s leading subcontractors in the industrial chemistry and pharmacy sectors. The facility specializes in a diverse range of dosage forms, including tablets, capsules, liquids, ointments, and aerosols. It operates under strict Good Manufacturing Practice (GMP) standards and provides comprehensive services from pilot-scale production to large-scale commercial manufacturing and packaging. Today, it serves as a strategic hub for Fareva's global pharmaceutical operations, catering to major international healthcare clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Istituto De Angeli.